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Abstract 
Background: Pregnant females are susceptible to oral conditions like gingivitis and 
pregnancy tumour, which affect both the mother and the developing foetus. Chlorhexidine, 
conventionally used to treat these conditions, causes side effects on long term use. Ayurvedic 
medications like G32 have been used for treating gingivitis.  
Objective: To compare efficacy of G32 with Chlorhexidine in treating pregnancy 
gingivitis after topical application.  
Materials and Methods: This was a double blind, randomised controlled trial 
conducted in a sample of 37 pregnant females, in second trimester, with gingivitis. They were 
randomly divided into two groups and were allotted Chlorhexidine gel (n=18) or G32 gum-
paint (n=19) for local application for one month. Plaque index (Silness and Löe, 1964) and 
Gingival index (Löe and Silness, 1963) were recorded at baseline and follow-up by a 
calibrated examiner. Statistical analysis was performed using paired t-test for intragroup 
comparison of mean plaque and gingival scores, and independent t-test for intergroup 
comparison of mean percentage reduction in plaque and gingival scores.  
Results: Both test and control groups showed a significant reduction in plaque and 
gingivitis. The percentage reductions in plaque and gingivitis were similar among the two 
groups.  
Conclusion: G32 is effective in treating pregnancy gingivitis and can be economical 
alternative to Chlorhexidine, with lesser side effects. 
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Introduction:  
 Pregnancy has far-reaching 
systemic effects extending beyond the 
reproductive organs. These effects are the 
end results of complex hormonal, 
immunologic, dietary, and behavioural 
changes occurring during pregnancy (1). 
These can include changes in the 
cardiovascular, respiratory and 
gastrointestinal systems, as well as 
changes in the oral cavity and increased 
susceptibility to oral infection (2). The oral 
effects are primarily seen as gingival 
manifestations; mainly causing pregnancy-
associated gingivitis and pyogenic 
granuloma or pregnancy tumour. So 
maintaining a good oral health is important 
during pregnancy. 
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 The occurrence of pregnancy 
gingivitis has been acknowledged for a 
substantial period of time. The term was 
first described in 1877 (3), although 
descriptions of the condition had been 
given even earlier in 1840 (4). It is 
extremely common and affects 30-75% of 
all pregnant women (5, 6). 
 Gingival inflammatory changes in 
pregnancy usually begin during the second 
month and increase in severity through the 
eighth month, after which an abrupt 
decrease occurs in the symptoms (7, 8). 
The greatest involvement appears to be in 
gingivae of the anterior teeth, with 
interproximal sites most commonly 
affected (9). The interproximal papillae 
become red, oedematous and tender to 
palpation, and they bleed easily if 
subjected to trauma (2). Various studies 
have confirmed that the prevalence and 
severity of gingival inflammation is 
significantly higher in pregnant women 
compared to postpartum, and appears 
unrelated to the amount of plaque present. 
Also pre-existing gingivitis or 
periodontitis in pregnant women has been 
noted to worsen dramatically (9). 
 Even a healthy pregnancy causes 
major changes in maternal anatomy, 
physiology and metabolism. These patients 
have a heightened awareness of and 
sensitivity to taste, smell and 
environmental temperature. Unpleasant 
tastes and odours can cause severe nausea 
or even gagging and vomiting (2). 
Although these adaptations of maternal 
body are normal, they do necessitate 
consideration and adjustments in treatment 
by any dentist, who is providing oral 
health care and prescribing medications for 
the patient.  
 Routine general dentistry should be 
done in the second trimester of pregnancy 
only, due to organogenesis occurring 
during the first trimester and increased 
uterine size in the third trimester, making 
sitting in the dental chair uncomfortable. 
Also nausea generally ceases by the end of 
the first trimester. Any treatment should be 
directed toward controlling disease, 
maintaining a healthy oral environment 
and preventing potential problems that 
could occur later in pregnancy or during 
the postpartum period. 
 Nevertheless, a treatment for 
gingivitis is definitely needed, as the lack 
of care of gums and teeth affects both the 
mother and the foetus. Severe gingival 
disease during pregnancy and the 
periodontal disease, which progresses from 
untreated gingivitis, can lead to premature 
delivery and low birth weight of the baby 
(10, 11). Thorough oral hygiene measures, 
including tooth brushing and flossing, are 
recommended to prevent occurrence of 
these diseases. Patients with severe 
gingivitis may require professional 
cleaning, along with mouth rinses like 
Chlorhexidine. More severe cases, if do 
not regress, need surgical therapy (12) 
which is not advisable during pregnancy. 
So the non-surgical treatment is the best 
approach.  
 Chlorhexidine is a known 
therapeutic agent used for treating 
gingivitis in general and also in pregnancy 
gingivitis. It is a dicationic bisguanide with 
pronounced antiseptic, antibacterial, 
antifungal and antiplaque properties. It is 
available as oral rinse (0.2% and 0.12%) 
and gel (1%). Many studies have shown 
that the long term use of Chlorhexidine 
may cause side effects ranging from as 
mild as staining of oral surfaces, such as 
tooth surfaces, restorations, and the 
dorsum of the tongue and a transient 
alteration in taste perception, to as severe 
as hypersensitivity, generalized allergic 
reactions and oro-pharyngeal cancer (13). 
High content of alcohol (12%) in this 
product has been a point of concern for use 
in pregnancy and so it has been placed 
under category ‘B’ for usage in pregnant 
females (14).  
 Under such circumstances, it has 
become vital to explore safe alternatives to 
Chlorhexidine. Many ayurvedic 
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formulations have been tested and have 
been proved to be effective in treating 
gingival diseases, with fewer deleterious 
effects. Many formulations like Salvadora 
persica (Miswak), Triphala, Propolis, 
Azadirachta indica (Neem) have been 
widely used (15-18).  
 G32, used in this study, is one such 
ayurvedic preparation. It is available for 
local application, in an easily crushable 
tablet form and as gum paint. The main 
ingredients in this ayurvedic preparation 
include Bakul, Chok, Katha, Laving, 
Fatakdi, etc. (Appendix A). It has anti-
inflammatory, antiseptic, antibacterial, 
astringent, anodyne, styptic and healing 
actions. Various studies have shown it to 
be effective in treating gingivitis (19-21) 
and pregnancy-induced gingivitis (22). 
These studies have shown that it has 
minimal side effects and has good 
compliance of the patients. However, no 
studies have been conducted till this date 
that compare G32 with Chlorhexidine, the 
existing ‘gold standard’ for gingivitis (23). 
So this study was conducted with an aim 
to compare the effectiveness of ayurvedic 
formulation, G32 with Chlorhexidine in 
treating pregnancy gingivitis. 
 
Constituents of G32 (19-22) 
Bakul (Mimosops elangi) -  80 mg. 
Chok (Calcium Carbonate) - 75 mg. 
Katho (Acacia catechu) -  40 mg. 
Laving (Myrtus 
caryophyllus) 
-  20 mg. 
Chikani Sopari (Areca 
catechu) 
-  20 mg. 
Fatakadi (Alumen) -  20 mg. 
Mayafal (Quercus infectoria) -  20 mg. 
Elaichi (Elettaria 
cardamomum) 
-  10 mg.  
Sonageru (Silicate of 
Alumina and Iron Oxide) 
-  10 mg. 
Jiru (Carum carvi) -  10 mg. 
Majith (Rubia cordifolia) -  10 mg. 
Pashanbed (Saxifrua 
ligulata) 
-  10 mg. 
Vavding (Embelia ribes) -  10 mg. 
Pipala ni Lakh (Ficus 
religiosa) 
-  10 mg. 
Samudrafin (Os sapiae) -  10 mg. 
Vajradanti (Barleria prioitis) -  10 mg. 
Taj (Cinnamimum cassia) -  5 mg. 
Mari (Piper nigrum) -  5 mg. 
Sajikhar (Sodium carbonate 
impure) 
-  5 mg. 
Kulinjan (Alpinia chinensis) -  5 mg. 
Pipar (Piper longum) -  5 mg. 
Kapur (Camphora 
officinarum) 
-  5 mg. 
Kuth (Uncaria gambier) -  5 mg. 
 
Objectives: 
 To evaluate the effectiveness of G32 
gum-paint in reducing dental plaque 
and gingivitis in pregnant females.  
 To compare its effectiveness with 
Chlorhexidine gel.   
 
Materials and methods: 
 This was a parallel design, 
randomised controlled trial, conducted on 
pregnant females with gingivitis, in their 
second trimester. The examinations were 
performed in the Ante-natal 
Gynaecological clinics of Dr. T.M.A. Pai 
Hospital, Udupi (Karnataka, India). The 
study was approved by the Kasturba 
Hospital Institutional Ethics Committee, 
Manipal (IEC 82/2011). An informed 
consent was taken from all the study 
participants before their inclusion.  
 
Sample selection –  
 The pregnant females, aged 20-35 
years, who were in their second 
trimester and had signs of moderate to 
severe gingivitis, with or without 
plaque or debris, were included in the 
study.  
 Those who had medical complications 
related to pregnancy, or any medical 
disorders or chronic/acute infections 
other than dental infection, requiring 
any kind of intervention, or reported a 
recent history of antibiotic 
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administration for any reason, were 
excluded from the sample. 
The final sample comprised of 37 
pregnant females who were randomly 
divided into two groups. 19 females in the 
test group were given G32 Alarsin gum-
paint (ALARSIN, Mumbai), while 18 
others formed the control group and were 
given Chlorhexidine gel (Hexigel, ICPA, 
Mumbai). Both the groups were instructed 
to apply the medicament and massage it 
over gums twice a day, along with their 
existing oral hygiene practices. The effects 
of the medicaments were assessed after 
one month of usage.  
 
Examination  
 This trial was conducted from 
March, 2011 to June, 2011. All the 
pregnant females attending regular ante-
natal check-ups in the Gynaecology Dept. 
were examined for their oral health status 
by the principal investigator, while general 
medical examination was performed by 
other investigator. The females with 
moderate to severe gingivitis (gingival 
scores ≥ 1) were included in the study after 
taking consent.  
 The participants’ information 
relating their demographics (age, 
education, income and address), months of 
pregnancy, personal oral habits, oral 
hygiene practices were recorded by one of 
the investigators, after interviewing them. 
Self-perceived oral health status was also 
recorded on a 5-point Likert scale, ranging 
from ‘excellent’ to ‘poor’. 
 This was followed by clinical oral 
examination which was performed by the 
principal investigator. The Gingival and 
Plaque scores were assessed using the Löe 
and Silness Index (1963) (24) and Silness 
and Löe Index (1964)
 
(25), respectively. 
These indices were calculated on selected 
maxillary and mandibular teeth for all the 
patients, using a mouth mirror and dental 
probe. The Gingival scores ranged from 0-
3 depending on the severity of 
inflammation in gingival margin. 
Similarly, the Plaque scores ranged from 
0-3 depending upon the thickness of 
plaque at gingival area of the tooth. Only 
one trained examiner did all the 
examinations to prevent the inter-examiner 
bias. Intra-examiner reliability was 
assessed by the kappa coefficient. The 
kappa values for Gingival and Plaque 
scores were 0.81 and 0.78 respectively.  
 Followed by this, the participants 
were randomly allotted one of the two 
medicaments in wrapped bottles, for one 
month usage. These bottles were 
sequentially numbered by an investigator 
who was not a part of the clinical 
examination. The subjects were instructed 
to thoroughly massage the medicament 
over gums and surrounding areas, with the 
help of finger-tip and were advised to keep 
it for minimum five minutes, and then 
rinse with fresh water, without swallowing 
it. This procedure was to be repeated twice 
daily for the first 15 days, in morning and 
at bed time.  
 
Interim Review  
 After the first 15 days, a reminder 
call was made by the investigator to 
enquire about the compliance to the 
instructions. The patients were asked if 
they experienced any change in the 
condition of their gums. They were 
instructed to continue using the 
medicament once daily (in morning) for 
the next 15 days.  
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Follow-up  
 All the females were examined at 
the end of one month for all the parameters 
evaluated at the baseline. The side effects, 
if any, were also recorded at this visit. The 
females were instructed for better oral 
hygiene methods and importance of oral 
health in pregnancy was reinforced. They 
were also advised for a dental visit soon 
after their delivery.  
 
Data analysis  
 All the data were analysed using 
the SPSS version 16.0. The intragroup 
changes in pre-test and post-test plaque 
and gingival scores were evaluated using a 
Paired t-test. Post-test plaque and gingival 
scores between the test and control groups 
were compared using Independent t-test. A 
p-value ≤ 0.05 was considered to be 
statistically significant.  
 
Results 
 A total of 400 pregnant females in 
their second trimester were examined, and 
69 females that fulfilled the inclusion 
criteria were selected. From these, 37 
females consented to participate in the 
study. The most common reason for not 
participating in the study was 
apprehension on part of the mothers about 
the possible risk to their foetuses. The 
females, who consented, were randomly 
divided into Chlorhexidine (n=18) and 
G32 (n=19) groups.  
 Out of these 37 pregnant females 
who were examined at the baseline, about 
80% (29 females) perceived their oral 
health status as ‘fair’. None of them 
perceived their oral status as ‘excellent’.  
 Three females were lost to follow-
up of 4 weeks. Two females prematurely 
withdrew from the study, because of 
nausea; one each from the test and the 
control groups. One female from the test 
group failed to return for the post-test 
examination. Hence, the final sample of 34 
females was analysed, with 17 patients in 
each group.  
 The mean age of the females in 
Chlorhexidine and G32 groups was 28.3 (± 
2.1) and 26.5 (± 3.6) years respectively, 
with a range of 20-33 years. The mean 
duration of pregnancy was 4.52 (± 0.8) and 
4.32 (± 0.9) months respectively, with a 
range of 3-6 months. The mean baseline 
plaque scores were 1.93 (± 0.5) and 1.64 
(± 0.4) for Chlorhexidine and G32 groups 
respectively. Similarly, the mean baseline 
gingival scores were 1.94 (± 0.5) and 1.76 
(± 0.3) respectively. There was no 
statistically significant difference between 
the test and control groups for mean age (p 
= 0.08), duration of pregnancy (p = 0.49), 
and plaque (p = 0.06) and gingival (p = 
0.22) scores. (Table 1) 
 
Table 1 – Baseline characteristics of participants of Chlorhexidine and G32 groups 
Treatment 
No. of 
Patients 
Mean Age 
(years) 
Mean duration 
of pregnancy 
(months) 
Mean Plaque 
Scores (±SD) 
Mean Gingival 
Scores (±SD) 
Chlorhexidine 17 28.37 4.52 1.93±0.52 1.94±0.49 
G32 17 26.59 4.32 1.64±0.33 1.76±0.32 
 The plaque scores reduced from 1.93 (± 0.5) to 0.79 (± 0.4) in the Chlorhexidine 
group, while in G32 group, a reduction from 1.64 (± 0.4) to 0.87 (± 0.4) was seen in the 
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plaque scores. The paired t-test showed that reduction in the plaque scores in both the study 
groups was statistically significant (p = 0.001). (Table 2) 
 
Table 2 – Comparison of pre- and post-test plaque scores in both the study groups  
Treatment 
Pre-test plaque 
(±SD) 
Post-test plaque 
(±SD) 
Mean 
Difference 
(±SD) 
Percentage 
reduction 
P-value 
Chlorhexidine 1.93±0.52 0.79±0.39 1.14±0.48 59% 0.001* 
G32 1.64±0.33 0.87±0.41 0.77±0.38 52.9% 0.001* 
* – P-value <0.05 considered significant 
Paired t-test – Comparing intragroup pre- and post- plaque scores  
 The gingival scores reduced from 1.94 (± 0.5) to 0.75 (± 0.3) in the Chlorhexidine 
group, while in G32 group, these reduced from 1.76 (± 0.3) to 0.72 (± 0.4). This reduction in 
both the study groups was found to be statistically significant (p ≤ 0.001). (Table 3) 
 
Table 3 – Comparison of pre- and post-test gingival scores in both the study groups 
Treatment 
Pre-test 
gingivitis 
(±SD) 
Post-test 
gingivitis 
(±SD) 
Mean 
Difference 
(±SD) 
Percentage 
reduction 
P-value 
Chlorhexidine 1.94±0.49 0.75±0.32 1.18±0.37 61% <0.001* 
G32 1.76±0.32 0.72±0.38 1.04±0.44 58.7% 0.001* 
* – P-value <0.05 considered significant 
Paired t-test – Comparing intragroup pre- and post- gingival scores 
 The plaque scores showed a mean percentage reduction of 59% in Chlorhexidine 
group and 53% in G32 group. This difference was not found to be statistically significant 
following the independent t-test (p = 0.48). The gingival scores showed a mean percentage 
reduction of 61% in Chlorhexidine group and 58% in G32 group. The independent t-test 
showed that this difference was not statistically significant (p = 0.64). (Table 4) 
 
Table 4 – Comparison of the percentage reduction of plaque and gingival scores between 
Chlorhexidine and G32 groups –  
Characteristics 
Percentage reduction 
Chlorhexidine 
Percentage 
reduction G32 
P-value 
Plaque Scores 58% 53% 0.484 
Gingival Scores 61% 58% 0.64 
P-value <0.05 considered significant 
Independent t-test – Comparing intergroup changes in scores 
 
Discussion: 
This study was a parallel designed, 
double blind, randomised controlled 
clinical trial conducted on pregnant 
females with gingivitis, in their second 
trimester. It aimed to assess the 
effectiveness of G32 as compared to 
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Chlorhexidine in treatment of pregnancy 
gingivitis. 
 Plaque and Gingival index were 
used to assess the oral health status of the 
subjects. Previous clinical trials have used 
these indices as effective parameters to 
evaluate the efficacy of the active 
components in preparations used in 
treatment of gingivitis (26-28).  
 Chlorhexidine is the gold standard 
for the treatment of gingivitis (23). It is 
also widely recommended for the 
treatment of pregnancy gingivitis (12). 
Previous studies have reported that the gel 
form of Chlorhexidine is more effective 
than the mouthwash (18). Hence, the gel 
form was used in this study, as it had an 
added advantage of better comparability 
with the ayurvedic medicament, as both 
are applied in similar manner.  
 G32 is an ayurvedic formulation, 
known for many years, effective in treating 
gingivitis (20, 21) and pregnancy 
gingivitis (22). These studies showed that 
scaling, curetting or surgical procedures 
for treating gingivitis could be avoided by 
the local application of G32. Similar 
findings were reported in this study. A 
mere local application of G32 had brought 
about 53% reduction in dental plaque and 
58% reduction in gingival inflammation.  
 The mean Plaque and Gingival 
Index scores reduced significantly over the 
trial period for both the groups. The 
difference in reduction of these scores in 
both the groups was not statistically 
significant, indicating that G32 is as 
effective as Chlorhexidine in reducing the 
plaque and gingival scores in this sample 
of pregnant females.  
 The participants were enquired 
about any side effects of the drugs 
experienced during the duration of one 
month trial. Few of the participants had 
complaint of nausea during this trial. 
These females gave a history of severe 
nausea during their first trimester. While 
some of them continued using the drugs, 
two of them withdrew themselves from the 
study prematurely.  
 Chlorhexidine formulations contain 
about 11.6% alcohol, as a preservative and 
a semi-active ingredient. Excessive use of 
alcohol based products cause allergy, 
desiccation of oral mucosa, staining and 
change in taste perception. A significant 
risk of developing oro-pharyngeal cancer 
exists with the long term use of these 
products (29). The use of these products in 
pregnant females is a matter of great 
concern. G32 is a water based product, 
causing none or minimal side effects of 
this nature, even on a long term use. It has 
a pleasant taste. Hence, the compliance of 
the patients would be better. Moreover, it 
was observed that G32 was economical to 
be used for a long duration than 
Chlorhexidine gel or mouthwash.  
 The major limitations of this study 
were the short duration of follow-up and 
small sample. Also, the sample could be 
drawn only from second trimester pregnant 
females due to ethical constraints. Further, 
no differentiation could be made for cases 
of ‘Gingivitis’ or ‘Pregnancy Gingivitis’, 
either through history or histologically.  
 Nevertheless, this study has 
evidently shown the effectiveness of G32 
in treatment of pregnancy gingivitis. 
Future studies are recommended to 
evaluate the reduction in amount of 
bleeding, reduction of attachment loss, 
effect on initial caries and the 
microbiological changes brought about by 
G32. Also the effects on pregnancy 
outcomes can be examined in longitudinal 
trials in pregnant females. Additional 
larger studies are needed to determine 
whether these findings are applicable to 
other populations, and to the treatment 
delivered at other stages of pregnancy.  
 During the course of this study, it 
was noticed that most of the pregnant 
females did not perceive their oral hygiene 
status as poor. Many were not aware of 
any disease in their oral cavity, while 
others were not sure if they needed to get 
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some treatment for their ailments. 
Moreover, quite a few females with 
gingivitis refused to undergo any treatment 
for their gingival disease. It was evident 
that pregnant females were not aware of 
the importance and the harmlessness of the 
oral hygiene procedures during pregnancy. 
Hence, there is a need to propagate the fact 
that the chemical methods of oral hygiene, 
like G32 and also Chlorhexidine, are safe 
and harmless to be used even during 
pregnancy.  
 
Conclusion:  
This study concluded that G32 
gum-paint is effective in reducing plaque 
and gingival inflammation in pregnant 
females. It can be an efficient, safe and 
cost-effective alternative to Chlorhexidine 
in the treatment of pregnancy gingivitis. 
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